Products
IP Reports
Search
Patexia Concierge
Patent Analyzer
Trademark Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Search
Login
Join
Patexia
Research
Case number
1:23-cv-01459
Lawsuits
Summary
Related Cases
Documents
Discussions
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al > Related Cases
Number
Title
Filing date
1:22-cv-00294
Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al
Mar 4, 2022
1:22-cv-00295
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
Mar 4, 2022
1:22-cv-00298
Novo Nordisk Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
Mar 4, 2022
1:22-cv-00299
Novo Nordisk Inc. et al v. Alvogen, Inc.
Mar 4, 2022
1:22-cv-00023
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
Mar 18, 2022
1:22-md-03038
In Re: Ozempic (Semaglutide) Patent Litigation
Aug 5, 2022
1:22-cv-01040
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
Aug 8, 2022
1:23-cv-00101
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
Jan 27, 2023
1:23-cv-00013
Novo Nordisk, Inc. et al v. Viatris Inc. et al
Jan 27, 2023
IPR2023-00723
Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S
Mar 16, 2023
1:24-cv-00050
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
Jan 12, 2024
1:24-cv-00067
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
Jul 2, 2024
1:24-cv-00775
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
Jul 1, 2024
2nd Annual Patexia Mixer
Our second Mixer will be on January 18th in Santa Monica. Make sure to
Register Today
Menu
Log In
Products
IP Reports
Search
Patexia Concierge
Patent Analyzer
Trademark Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us